The most significant achievements in gut microbiome science in 2018
27 Dec 2018by GMFH Editing Team
GMFH continue to cover the important progress made in our knowledge of the gut microbiota's impact on wellbeing and disease.
by GMFH Editing Team
GMFH continue to cover the important progress made in our knowledge of the gut microbiota's impact on wellbeing and disease.
The scientific community has reacted to the publication in Cell that pointed to the reduced effectiveness of probiotics by questioning these investigations and defending the benefits of certain bacteria.
A new review highlights current research on how changes in the gut microbiota alter interactions with the immune system, leading to the development of food sensitivities.
by GMFH Editing Team
Western diets high in fats and sugars, modern lifestyles with stress and sedentarism and the indiscriminate use of antibiotics together with other frequently prescribed drugs -such as non-steroidal anti-inflammatory drugs and proton pump inhibitors- are major drivers of changes in microbiota composition and gut barrier disruption. (Dr. Maria Rescigno)
by Andrea Hardy
Alterations in the gut microbiota could prevent type 2 diabetes, with these changes playing a fundamental role in detecting both the condition and the onset of obesity.
During TEDxHa’pennyBridge in Dublin, Principal Investigator at the APC Microbiome Institute in Cork, John Cryan, gave a talk about the connection between the gut, brain and microbiome, and its impact on psychiatric and immune disorders.
by Mary Ellen Sanders
The board members of the International Scientific Association for Probiotics and Prebiotics (ISAPP) have responded to two scientific papers published in Cell.
by Andreu Prados
In the presence of pathogenic invaders and other noxious insults, a resilient immune response is crucial to effectively eliminate the source of stimulation in a way that does not harm the host.
Here is an interview with the Italian microbiologist Lorenzo Morelli, whose research focuses on the probiotics present in fermented foods as an alternative to medical treatments.
by Megan Mouw
Researchers have developed a new probiotic-cocktail of infant-gut origin that modulates the gut microbiota of mice (in-vivo) and human feces (ex-vivo) by increasing native production of SCFAs.